Alphamab Oncology9966 
$0.322.03%24h
2.03%24h
Global rank14480
Market cap$310.74M
Change 7d-1.95%
YTD Performance-62.43%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Market capitalization of Alphamab Oncology (9966)
As of December 2024, Alphamab Oncology has a market cap of $310.74M. This makes Alphamab Oncology the world's 14480th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of Alphamab Oncology from 2019 to 2024
-
Value:-
Market cap history of Alphamab Oncology from 2019 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $526.15M | -35.99% |
| 2023 | $822.04M | -38.52% |
| 2022 | $1.34B | -20.59% |
| 2021 | $1.68B | -17.27% |
| 2020 | $2.04B | 17.43% |
| 2019 | $1.73B | - |
9966 Market Cap Today is $310.74M 2.03% - 6 Dec 2024
View largest stocks by market cap 
